BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20005184)

  • 1. Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.
    Wiegand R; Wu J; Sha X; LoRusso P; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):333-9. PubMed ID: 20005184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase.
    Parise RA; Shawaqfeh M; Egorin MJ; Beumer JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):141-7. PubMed ID: 18692448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and sensitive method for determination of veliparib (ABT-888), in human plasma, bone marrow cells and supernatant by using LC/MS/MS.
    Reinhardt S; Zhao M; Mnatsakanyan A; Xu L; Ricklis RM; Chen A; Karp JE; Rudek MA
    J Pharm Biomed Anal; 2010 May; 52(1):122-8. PubMed ID: 20071126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma.
    Wiegand R; Wu J; Sha X; LoRusso P; Heath E; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1460-4. PubMed ID: 19349217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma.
    Yan T; Li H; Deng L; Guo Y; Yu W; Fawcett JP; Zhang D; Cui Y; Gu J
    J Pharm Biomed Anal; 2008 Dec; 48(4):1225-9. PubMed ID: 18838240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ON 01910.Na, a mitotic progression modulator, in human plasma.
    Li J; Zhao M; Jimeno A; He P; Ramana Reddy MV; Hidalgo M; Donehower RC; Rudek MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):198-204. PubMed ID: 17588831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry.
    Wiegand R; Wu J; Shields AF; Lorusso P; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 891-892():64-70. PubMed ID: 22410089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay for quantitation of the total and unbound RO4929097, a γ-secretase inhibitor targeting Notch signaling, in human plasma.
    Wu J; Wiegand R; LoRusso P; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1537-43. PubMed ID: 21497565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ABT-751, ABT-751 glucuronide, and ABT-751 sulfate in human plasma for clinical pharmacology studies.
    Rudek MA; Zhao M; He P; Messersmith WA; Baker SD
    J Pharm Biomed Anal; 2006 Sep; 42(2):253-60. PubMed ID: 16765012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of azilsartan and chlorthalidone in rat and human plasma by liquid chromatography-electrospray tandem mass spectrometry.
    Ramakrishna R; Puttrevu SK; Bhateria M; Bala V; Sharma VL; Bhatta RS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():185-97. PubMed ID: 25899870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma.
    Zhao M; Rudek MA; Mnasakanyan A; Hartke C; Pili R; Baker SD
    J Pharm Biomed Anal; 2007 Jan; 43(2):784-7. PubMed ID: 16971082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
    Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
    Bhaumik U; Ghosh A; Sarkar AK; Bose A; Selvan PS; Sengupta P; Chakraborty US; Ghosh D; Pal TK
    J Pharm Biomed Anal; 2008 Dec; 48(5):1404-10. PubMed ID: 18986788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.
    de Bruijn P; Moghaddam-Helmantel IM; de Jonge MJ; Meyer T; Lam MH; Verweij J; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2009 Dec; 50(5):977-82. PubMed ID: 19628352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Candesartan in Human Plasma with Liquid Chromatography - Tandem Mass Spectrometry.
    Forjan V; Cvitkovič Maričič L; Prosen H; Brodnjak Vončina D
    Acta Chim Slov; 2016; 63(1):38-46. PubMed ID: 26970787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a liquid chromatography coupled with tandem mass spectrometry method for determining total and unbound pamiparib in human plasma and brain tumors.
    Jiang J; Bao X; Yue Y; Schiff D; Bindra R; Li J
    Biomed Chromatogr; 2022 Dec; 36(12):e5478. PubMed ID: 35938683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1'-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection.
    Svanström C; Hansson GP; Svensson LD; Sennbro CJ
    J Pharm Biomed Anal; 2012 Jan; 58():71-7. PubMed ID: 21993197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.